The effects of dexmedetomidine and remifentanil on hemodynamic stability and analgesic requirement after craniotomy: A randomized controlled trial

Journal of Neurosurgical Anesthesiology

Volumn 28, Issue 4, 2016, Pages 282-290

  Rajan, Shobana ^a   Hutcherson, Matthew T ^a   Sessler, Daniel I ^a   Kurz, Andrea ^a   Yang, Dongsheng ^a   Ghobrial, Michael ^b   Liu, Jinbo ^a   Avitsian, Rafi ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b FAIRVIEW HOSPITAL   (United States)

Author keywords

Anesthesia; Cognitive recovery; Craniotomy; Dexmedetomidine; Hemodynamics; Postoperative pain; Remifentanil

Indexed keywords

DEXMEDETOMIDINE; FENTANYL; MORPHINE; PROPOFOL; REMIFENTANIL; ROCURONIUM; SEVOFLURANE; HYPNOTIC SEDATIVE AGENT; PIPERIDINE DERIVATIVE;

ADULT; ALDRETE SCORE; ARTICLE; BLOOD PRESSURE REGULATION; BRAIN TUMOR; CANCER SURGERY; COMPARATIVE STUDY; CONTROLLED STUDY; CRANIOTOMY; DRUG USE; ELECTIVE SURGERY; ENDOTRACHEAL INTUBATION; FEMALE; GENERAL ANESTHESIA; HEART RATE; HUMAN; INTRAOPERATIVE PERIOD; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NAUSEA; NURSING USAGE SCORE; OUTCOME ASSESSMENT; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHIVERING; SHORT ORIENTATION MEMORY CONCENTRATION TEST SCORE; VISUAL ANALOG SCALE; VOMITING; ANALGESIA; DRUG EFFECTS; HEMODYNAMICS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; STATISTICS AND NUMERICAL DATA;

ANALGESIA; CRANIOTOMY; DEXMEDETOMIDINE; FEMALE; HEMODYNAMICS; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; PIPERIDINES; POSTOPERATIVE COMPLICATIONS;

EID: 84944345959     PISSN: 08984921     EISSN: 15371921     Source Type: Journal    
DOI: 10.1097/ANA.0000000000000221     Document Type: Article

References (44)

1. Shribman AJ, Smith G, Achola KJ. Cardiovascular and catechol-amine responses to laryngoscopy with and without tracheal intubation. Br J Anaesth. 1987;59:295-299.
2. Uyar AS, Yagmurdur H, Fidan Y, et al. Dexmedetomidine attenuates the hemodynamic and neuroendocrinal responses to skull-pin head-holder application during craniotomy. J Neurosurg Anesthesiol. 2008;20:174-179.
3. Gibson BE, Black S, Maass L, et al. Esmolol for the control of hypertension after neurologic surgery. Clin Pharmacol Ther. 1988;44:650-653.
4. Kross RA, Ferri E, Leung D, et al. A comparative study between a calcium channel blocker (Nicardipine) and a combined alpha-beta-blocker (Labetalol) for the control of emergence hypertension during craniotomy for tumor surgery. Anesth Analg. 2000;91: 904-909.
5. Bebawy JF, Houston CC, Kosky JL, et al. Nicardipine is superior to esmolol for the management of postcraniotomy emergence hyper-tension: a randomized open-label study. Anesth Analg. 2015;120: 186-192.
6. Basali A, Mascha EJ, Kalfas I, et al. Relation between perioperative hypertension and intracranial hemorrhage after craniotomy. Anesthesiology. 2000;93:48-54.
7. Mastronardi P, Dellacasa P. Observational study on the use of remifentanil in general anesthesia. Drug utilisation research. Minerva Anestesiol. 2004;70:605-616.
8. Beers R, Camporesi E. Remifentanil update: clinical science and utility. CNS Drugs. 2004;18:1085-1104.
9. Pournajafian A, Rokhtabnak F, Kholdbarin A, et al. Comparison of remifentanil and fentanyl regarding hemodynamic changes due to endotracheal intubation in preeclamptic parturient candidate for cesarean delivery. Anesth Pain Med. 2012;2:90-93.
10. Zhao M, Joo DT. Enhancement of spinal N-methyl-D-aspartate receptor function by remifentanil action at delta-opioid receptors as a mechanism for acute opioid-induced hyperalgesia or tolerance. Anesthesiology. 2008;109:308-317.
11. Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology. 2006;104:570-587.
12. Joly V, Richebe P, Guignard B, et al. Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine. Anesthesiology. 2005;103:147-155.
13. Mordhorst C, Latz B, Kerz T, et al. Prospective assessment of postoperative pain after craniotomy. J Neurosurg Anesthesiol. 2010;22:202-206.
14. Ma D, Hossain M, Rajakumaraswamy N, et al. Dexmedetomidine produces its neuroprotective effect via the alpha 2A-adrenoceptor subtype. Eur J Pharmacol. 2004;502:87-97.
15. Hall JE, Uhrich TD, Barney JA, et al. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg. 2000;90:699-705.
16. Panzer O, Moitra V, Sladen RN. Pharmacology of sedative-analgesic agents: dexmedetomidine, remifentanil, ketamine, volatile anesthetics, and the role of peripheral Mu antagonists. Anesthesiol Clin. 2011;29:587-605.
17. Garg N, Panda NB, Gandhi KA, et al. Comparison of small dose ketamine and dexmedetomidine infusion for postoperative analgesia in spine surgery-a prospective randomized double-blind placebo controlled study. J Neurosurg Anesthesiol. 2015; [Epub ahead of print].
18. Song J, Ji Q, Sun Q, et al. The opioid-sparing effect of intraoperative dexmedetomidine infusion after craniotomy. J Neurosurg Anesthe-siol. 2015; [Epub ahead of print].
19. Mariappan R, Ashokkumar H, Kuppuswamy B. Comparing the effects of oral clonidine premedication with intraoperative dexme-detomidine infusion on anesthetic requirement and recovery from anesthesia in patients undergoing major spine surgery. J Neurosurg Anesthesiol. 2014;26:192-197.
20. Venn RM, Karol MD, Grounds RM. Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive caret. Br J Anaesth. 2002;88:669-675.
21. Katzman R, Brown T, Fuld P, et al. Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry. 1983;140:734-739.
22. Wade DT, Vergis E. The short orientation-memory-concentration test: a study of its reliability and validity. Clin Rehabil. 1999;13: 164-170.
23. Queally VR, Evans JJ, McMillan TM. Accuracy in scoring vignettes using the mini mental state examination and the short orientation memory concentration test. J Geriatr Psychiatry Neurol. 2010;23: 160-164.
24. Aldrete JA. The post-anesthesia recovery score revisited. J Clin Anesth. 1995;7:89-91.
25. Kiekkas P, Brokalaki H, Manolis E, et al. Patient severity as an indicator of nursing workload in the intensive care unit. Nurs Crit Care. 2007;12:34-41.
26. Miranda DR, de Rijk A, Schaufeli W. Simplified Therapeutic Intervention Scoring System: the TISS-28 items-results from a multicenter study. Crit Care Med. 1996;24:64-73.
27. Turan A, Atim A, Dalton JE, et al. Preoperative angiotensin-converting enzyme inhibitor use is not associated with increased postoperative pain and opioid use. Clin J Pain. 2013;29:1050-1056.
28. Turgut N, Turkmen A, Ali A, et al. Remifentanil-propofol vs dexmedetomidine-propofol-anesthesia for supratentorial craniot-omy. Middle East J Anaesthesiol. 2009;20:63-70.
29. Peng K, Wu S, Liu H, et al. Dexmedetomidine as an anesthetic adjuvant for intracranial procedures: meta-analysis of randomized controlled trials. J Clin Neurosci. 2014;21:1951-1958.
30. Tanskanen PE, Kytta JV, Randell TT, et al. Dexmedetomidine as an anaesthetic adjuvant in patients undergoing intracranial tumour surgery: a double-blind, randomized and placebo-controlled study. Br J Anaesth. 2006;97:658-665.
31. Feld JM, Hoffman WE, Stechert MM, et al. Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. J Clin Anesth. 2006;18:24-28.
32. Alipour M, Tabari M, Faz RF, et al. Effect of dexmedetomidine on postoperative pain in knee arthroscopic surgery; a randomized controlled clinical trial. Arch Bone Jt Surg. 2014;2:52-56.
33. Yamazaki K, Kaneda T, Suzuki T. Usefulness of additional dexmedetomidine administration in postoperative pain management after the scoliosis surgery. Masui. 2014;63:783-788.
34. Tong Y, Ren H, Ding X, et al. Analgesic effect and adverse events of dexmedetomidine as additive for pediatric caudal anesthesia: a meta-analysis. Paediatr Anaesth. 2014;24:1224-1230.
35. Afonso J, Reis F. Dexmedetomidine: current role in anesthesia and intensive care. Rev Bras Anestesiol. 2012;62:118-133.
36. Rajan S, Cata JP, Nada E, et al. Asleep-awake-asleep craniotomy: a comparison with general anesthesia for resection of supratentorial tumors. J Clin Neurosci. 2013;20:1068-1073.
37. Peng K, Jin XH, Liu SL, et al. Effect of intraoperative dexmedetomidine on post-craniotomy pain. Clin Ther. 2015;37: 1114-1121.
38. Gopalakrishna KN, Dash PK, Chatterjee N, et al. Dexmedetomi-dine as an anesthetic adjuvant in patients undergoing trans-sphenoidal resection of pituitary tumor. J Neurosurg Anesthesiol. 2015;27:209-215.
39. Hwang W, Lee J, Park J, et al. Dexmedetomidine versus remifentanil in postoperative pain control after spinal surgery: a randomized controlled study. BMC Anesthesiol. 2015;15:21.
40. Guignard B, Bossard AE, Coste C, et al. Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology. 2000;93:409-417.
41. Guignard B, Coste C, Costes H, et al. Supplementing desflurane-remifentanil anesthesia with small-dose ketamine reduces perioper-ative opioid analgesic requirements. Anesth Analg. 2002;95:103-108.
42. Glass PS, Gan TJ, Howell S. A review of the pharmacokinetics and pharmacodynamics of remifentanil. Anesth Analg. 1999;89:S7-14.
43. Kapila A, Glass PS, Jacobs JR, et al. Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology. 1995; 83:968-975.
44. Ohtani N, Kida K, Shoji K, et al. Recovery profiles from dexmedetomidine as a general anesthetic adjuvant in patients under-going lower abdominal surgery. Anesth Analg. 2008;107:1871-1874.